Yttrium 90 therapy for hepatocellular carcinoma: Is it any better than conventional external beam radiotherapy?
作者信息
Wigg Alan, Wallington Margaret
出版信息
Hepatology. 2012 Mar;55(3):981; author reply 981-2. doi: 10.1002/hep.25535.
PMID:22183954
Abstract
摘要
相似文献
1
Yttrium 90 therapy for hepatocellular carcinoma: Is it any better than conventional external beam radiotherapy?
Hepatology. 2012 Mar;55(3):981; author reply 981-2. doi: 10.1002/hep.25535.
2
Ablative Transarterial Radioembolization of a Parasitized Adrenal Artery for the Treatment of Hepatocellular Carcinoma.
J Vasc Interv Radiol. 2019 Mar;30(3):473-476. doi: 10.1016/j.jvir.2018.10.022.
3
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S83-8. doi: 10.1016/j.ijrobp.2006.02.061.
4
Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
J Vasc Interv Radiol. 2014 Jul;25(7):1073-4. doi: 10.1016/j.jvir.2014.04.008.
5
[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Rofo. 2010 Aug;182(8):660-70. doi: 10.1055/s-0029-1245380. Epub 2010 Apr 19.
6
Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?
Curr Opin Oncol. 2021 Jul 1;33(4):351-352. doi: 10.1097/CCO.0000000000000749.
7
Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
Minerva Gastroenterol Dietol. 2011 Sep;57(3):287-98.
8
Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
Chin Med J (Engl). 2001 Apr;114(4):433-4.
9
Apparent diffusion coefficient quantification as an early imaging biomarker of response for unresectable infiltrative hepatocellular carcinoma.
Abdom Imaging. 2015 Aug;40(6):1470. doi: 10.1007/s00261-014-0286-7.
10
A surreptitious trip to the lungs.
Ann Am Thorac Soc. 2014 Jan;11(1):137-40. doi: 10.1513/AnnalsATS.201310-359CR.
Zotero 插件